Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa Churchill

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Virology|May 27, 2005
Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndromeLachlan Gray, Jasminka Sterjovski, Melissa Churchill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Phagocytic efficiency of monocytes and macrophages obtained from Sydney blood bank cohort members infected with an attenuated strain of HIV-1Katherine Kedzierska, Melissa Churchill, Clare L V Maslin, et al.
AIDS (London, England)|November 6, 2013
Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cellsFiona Wightman, Hao K Lu, Ajantha E Solomon, et al.
The Journal of Infectious Diseases|November 20, 2004
Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementiaMelissa Churchill, Jasminka Sterjovski, Lachlan Gray, et al.
Journal of Virology|June 15, 2007
Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regionsErin E Verity, Dimitra Zotos, Kim Wilson, et al.
AIDS Research and Human Retroviruses|August 12, 2017
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 AntagonistsJacqueline K Flynn, Paula Ellenberg, Renee Duncan, et al.
Virology|November 17, 2009
Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infectionJessica Wade, Jasminka Sterjovski, Lachlan Gray, et al.
Blood|March 18, 2011
HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN productionAndrew N Harman, Joey Lai, Stuart Turville, et al.
Retrovirology|July 28, 2016
HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κBSuha Saleh, Hao K Lu, Vanessa Evans, et al.
AIDS (London, England)|July 14, 2018
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1Christina C Chang, Vivek Naranbhai, Jared Stern, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Virology|May 27, 2005
Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndromeLachlan Gray, Jasminka Sterjovski, Melissa Churchill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2003
Phagocytic efficiency of monocytes and macrophages obtained from Sydney blood bank cohort members infected with an attenuated strain of HIV-1Katherine Kedzierska, Melissa Churchill, Clare L V Maslin, et al.
AIDS (London, England)|November 6, 2013
Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cellsFiona Wightman, Hao K Lu, Ajantha E Solomon, et al.
The Journal of Infectious Diseases|November 20, 2004
Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementiaMelissa Churchill, Jasminka Sterjovski, Lachlan Gray, et al.
Journal of Virology|June 15, 2007
Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regionsErin E Verity, Dimitra Zotos, Kim Wilson, et al.
AIDS Research and Human Retroviruses|August 12, 2017
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 AntagonistsJacqueline K Flynn, Paula Ellenberg, Renee Duncan, et al.
Virology|November 17, 2009
Enhanced CD4+ cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infectionJessica Wade, Jasminka Sterjovski, Lachlan Gray, et al.
Blood|March 18, 2011
HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN productionAndrew N Harman, Joey Lai, Stuart Turville, et al.
Retrovirology|July 28, 2016
HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κBSuha Saleh, Hao K Lu, Vanessa Evans, et al.
AIDS (London, England)|July 14, 2018
Variation in cell-associated unspliced HIV RNA on antiretroviral therapy is associated with the circadian regulator brain-and-muscle-ARNT-like-1Christina C Chang, Vivek Naranbhai, Jared Stern, et al.
Pageof 3